secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0000950170-23-060245
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen Q3 revenue $84.0M, down 20.3% YoY; GAAP net loss $45.7M from $32.9M impairment
--------------------------------------------------------------------------------

- Total revenue $84.0M vs $105.4M in Q3 2022, down 20.3% YoY.
- GAAP net loss $45.7M vs $9.5M loss YoY; includes $32.9M non-cash impairment.
- Adjusted net loss $8.5M vs $4.1M loss; Adjusted EBITDA loss $5.5M vs $1.2M loss.
- Completed acquisition of Physio-Assist SAS, adding airway clearance portfolio.
- Cash $138.0M, no debt; focusing on returning to revenue growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023060245/0000950170-23-060245-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000095017023060245/ingn-20231107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-060245

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer